Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KMI vs GSK✓SelectedUSD · GSKKMI vs GSK performance historyLatest closeAs of-1.57%11/16
Stock and ETF performance explorer

KMI vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+146.6%
GSK return
+107.3%
Excess return
+39.3%
Maximum drawdown
-55.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.6%-0.1%-1.5%-1.5%
7D+2.8%-1.3%+4.1%+3.2%
30D-7.3%+2.7%-10.0%-8.2%
3M-3.4%+2.7%-6.1%-4.6%
6M-4.9%+3.3%-8.2%-6.5%
YTD+18.6%+6.5%+12.1%+14.4%
1Y+18.9%+10.7%+8.2%+13.1%
3Y+114.3%+64.4%+49.9%+68.1%
5Y+145.5%+46.7%+98.8%+98.0%
10Y+146.6%+109.4%+37.2%+64.4%
All+146.6%+107.3%+39.3%+64.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling